This is a StreetInsider.com Premium Only Page

NGM Biopharmaceuticals (NGM) –

Apr 15, 2024 07:58 AM Form 15-12G NGM BIOPHARMACEUTICALS

Apr 9, 2024 06:03 AM Form EFFECT NGM BIOPHARMACEUTICALS

Apr 8, 2024 08:06 PM Form 4 NGM BIOPHARMACEUTICALS For: Apr 05 Filed by: TCG Opportunity III GP, LLC

Apr 8, 2024 08:05 PM Form 4 NGM BIOPHARMACEUTICALS For: Apr 05 Filed by: Column Group IV-A, LP

Apr 8, 2024 08:04 PM Form 4 NGM BIOPHARMACEUTICALS For: Apr 05 Filed by: COLUMN GROUP L P

Apr 8, 2024 08:03 PM Form 4 NGM BIOPHARMACEUTICALS For: Apr 05 Filed by: GOEDDEL DAVID V

Apr 8, 2024 04:18 PM Form 4 NGM BIOPHARMACEUTICALS For: Mar 26 Filed by: Pierce Valerie L

Apr 8, 2024 04:17 PM Form 4 NGM BIOPHARMACEUTICALS For: Apr 05 Filed by: RIEFLIN WILLIAM JL

Apr 8, 2024 04:15 PM Form 4 NGM BIOPHARMACEUTICALS For: Apr 05 Filed by: Perlich Irene

Apr 8, 2024 04:15 PM Form 4 NGM BIOPHARMACEUTICALS For: Mar 26 Filed by: Viret Jean-Frederic

Apr 8, 2024 04:15 PM Form 4 NGM BIOPHARMACEUTICALS For: Apr 05 Filed by: WOODHOUSE DAVID J

Apr 8, 2024 04:14 PM Form 4 NGM BIOPHARMACEUTICALS For: Apr 05 Filed by: Ho Carole

Apr 8, 2024 04:13 PM Form 4 NGM BIOPHARMACEUTICALS For: Apr 05 Filed by: Hooper Suzanne Sawochka

Apr 8, 2024 04:13 PM Form 4 NGM BIOPHARMACEUTICALS For: Apr 05 Filed by: Guyer Shelly D

Apr 8, 2024 04:10 PM Form 4 NGM BIOPHARMACEUTICALS For: Apr 05 Filed by: PERLMUTTER ROGER M

Apr 8, 2024 04:09 PM Form 4 NGM BIOPHARMACEUTICALS For: Apr 05 Filed by: Lieu Hsiao D

Apr 5, 2024 11:23 AM Form 25-NSE NGM BIOPHARMACEUTICALS Filed by: Nasdaq Stock Market LLC

Apr 5, 2024 10:56 AM Form SC 13D/A NGM BIOPHARMACEUTICALS Filed by: COLUMN GROUP L P

Apr 5, 2024 10:55 AM Form S-8 POS NGM BIOPHARMACEUTICALS

Apr 5, 2024 10:54 AM Form S-8 POS NGM BIOPHARMACEUTICALS

Apr 5, 2024 10:54 AM Form S-8 POS NGM BIOPHARMACEUTICALS

Apr 5, 2024 10:53 AM Form S-8 POS NGM BIOPHARMACEUTICALS

Apr 5, 2024 10:52 AM Form S-8 POS NGM BIOPHARMACEUTICALS

Apr 5, 2024 10:41 AM Form POS AM NGM BIOPHARMACEUTICALS

Apr 5, 2024 10:11 AM Form 8-K NGM BIOPHARMACEUTICALS For: Apr 05

Apr 5, 2024 09:49 AM Form SC TO-T/A NGM BIOPHARMACEUTICALS Filed by: COLUMN GROUP L P

Apr 5, 2024 09:28 AM Form SC 13E3/A NGM BIOPHARMACEUTICALS Filed by: NGM BIOPHARMACEUTICALS INC

Apr 5, 2024 09:25 AM Form SC 14D9/A NGM BIOPHARMACEUTICALS Filed by: NGM BIOPHARMACEUTICALS INC

Apr 5, 2024 09:19 AM NGM Bio Announces Closing of Tender Offer

Apr 4, 2024 04:42 PM Form 10-K/A NGM BIOPHARMACEUTICALS For: Dec 31

Mar 29, 2024 04:57 PM Form SC 14D9/A NGM BIOPHARMACEUTICALS Filed by: NGM BIOPHARMACEUTICALS INC

Mar 22, 2024 05:31 PM Form SC TO-T/A NGM BIOPHARMACEUTICALS Filed by: COLUMN GROUP L P

Mar 22, 2024 05:22 PM Form SC 14D9/A NGM BIOPHARMACEUTICALS Filed by: NGM BIOPHARMACEUTICALS INC

Mar 22, 2024 05:20 PM Form SC 13E3/A NGM BIOPHARMACEUTICALS Filed by: NGM BIOPHARMACEUTICALS INC

Mar 22, 2024 01:34 PM Kuehn Law Encourages NGM, CTLT, SDPI, and HRT Investors to Contact Law Firm

Mar 19, 2024 05:30 PM NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting

Mar 12, 2024 05:30 AM Raymond James Downgrades NGM Biopharmaceuticals (NGM) to Market Perform 'Due to Possible Going Private Transaction'

Mar 11, 2024 05:22 PM NGM Biopharmaceuticals, Inc. (NGM) Tops Q4 EPS by 6c

Mar 11, 2024 04:15 PM Form 10-K NGM BIOPHARMACEUTICALS For: Dec 31

Mar 11, 2024 04:13 PM Form 8-K NGM BIOPHARMACEUTICALS For: Mar 11

Mar 11, 2024 04:05 PM NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 8, 2024 05:33 PM Form SC 13E3 NGM BIOPHARMACEUTICALS Filed by: NGM BIOPHARMACEUTICALS INC

Mar 8, 2024 05:22 PM Form SC 14D9 NGM BIOPHARMACEUTICALS Filed by: NGM BIOPHARMACEUTICALS INC

Mar 8, 2024 04:54 PM Form SC TO-T NGM BIOPHARMACEUTICALS Filed by: COLUMN GROUP L P

Feb 28, 2024 07:54 AM NGM Biopharmaceuticals (NGM) PT Lowered to $1.55 at B.Riley

Feb 28, 2024 07:34 AM B.Riley Downgrades NGM Biopharmaceuticals (NGM) to Neutral

Feb 27, 2024 04:55 PM TD Cowen Downgrades NGM Biopharmaceuticals (NGM) to Market Perform

Feb 27, 2024 08:47 AM Citi Downgrades NGM Biopharmaceuticals (NGM) to Neutral

Feb 26, 2024 05:16 PM Form SC 13D/A NGM BIOPHARMACEUTICALS Filed by: COLUMN GROUP L P

Feb 26, 2024 05:12 PM Form SC14D9C NGM BIOPHARMACEUTICALS Filed by: NGM BIOPHARMACEUTICALS INC